Publicacións en colaboración con investigadores/as de Hospital Clinic Barcelona (12)

2024

  1. Basic host response parameters to classify mortality risk in COVID-19 and community-acquired pneumonia

    Scientific reports, Vol. 14, Núm. 1, pp. 12726

2022

  1. Early Initiation of Corticosteroids Might be Harmful in Patients Hospitalized With COVID-19 Pneumonia: A Multicenter Propensity Score Analysis

    Archivos de Bronconeumologia, Vol. 58, Núm. 3, pp. 281-283

  2. Early Recognition of Low-Risk SARS-CoV-2 Pneumonia: A Model Validated With Initial Data and Infectious Diseases Society of America/American Thoracic Society Minor Criteria

    Chest, Vol. 162, Núm. 4, pp. 768-781

2020

  1. Consensus Document for Severe Asthma in Adults. 2020 Update

    Open Respiratory Archives, Vol. 2, Núm. 3, pp. 158-174

2019

  1. Efficacy and Safety of Reslizumab in Patients with Severe Asthma with Inadequate Response to Omalizumab: A Multicenter, Open-Label Pilot Study

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 7, Núm. 7, pp. 2277-2283.e2

2018

  1. Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: A network approach

    International Journal of COPD, Vol. 13, pp. 591-601

2017

  1. Asthma-COPD overlap is not a homogeneous disorder: Further supporting data

    Respiratory Research

  2. Consensus on the Asthma-COPD Overlap Syndrome (ACOS) Between the Spanish COPD Guidelines (GesEPOC) and the Spanish Guidelines on the Management of Asthma (GEMA)

    Archivos de Bronconeumologia, Vol. 53, Núm. 8, pp. 443-449

  3. Quality indicators of asthma care derived from the spanish guidelines for asthma management (GEMA 4.0): A multidisciplinary team report

    Journal of Investigational Allergology and Clinical Immunology

2016

  1. GEMA 4.0 Spanish guidelines of the management of Asthma

    Journal of Investigational Allergology and Clinical Immunology

2011

  1. Effects of omalizumab in Aspergillus-associated airway disease

    Thorax

2007

  1. Impacto de la EPOC en la vida diaria de los pacientes. Resultados del estudio multicéntrico EIME

    Archivos de Bronconeumologia, Vol. 43, Núm. 2, pp. 64-72